Biospecifics technologies corp (BSTC)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

19,134

4,999

12,769

13,972

17,597

13,176

13,381

12,960

12,558

7,333

6,422

6,029

9,031

4,763

4,747

6,964

9,514

5,137

7,488

8,547

10,733

9,810

9,711

8,840

8,934

5,624

4,606

4,017

7,248

3,383

3,823

3,788

5,778

3,196

3,795

5,020

2,470

Short term investments

85,084

84,239

69,089

71,304

66,899

67,707

58,429

53,585

48,751

51,973

48,166

45,115

38,839

44,254

45,075

36,607

32,277

28,347

23,442

19,245

13,010

10,900

7,794

7,793

7,973

6,966

6,726

7,966

4,962

5,120

5,190

5,000

5,000

5,000

5,000

5,360

5,360

Accounts receivable

17,750

19,065

17,768

16,729

16,476

16,518

14,455

12,893

19,165

4,655

4,681

4,663

4,928

3,810

3,846

4,279

3,787

2,547

4,211

3,001

3,656

2,938

3,089

2,042

1,921

5,004

5,044

3,903

2,910

5,082

3,205

2,820

1,847

3,236

1,699

877

1,986

Deferred royalty buy-down

-

-

0

0

0

184

-

-

-

1,794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax receivable

-

-

-

-

-

-

-

-

-

-

56

290

282

494

0

884

928

916

1,174

708

639

653

751

1,272

293

255

51

51

51

51

71

51

244

244

379

185

185

Investment interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

137

119

66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

16

16

16

110

99

97

94

83

79

70

88

637

826

1,049

1,309

1,289

1,299

0

Deferred royalty buy-down

-

-

-

-

-

-

601

1,124

1,648

-

1,566

1,535

1,491

1,451

1,215

1,139

1,184

1,017

802

640

628

569

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

898

966

836

1,012

604

646

801

836

580

623

673

800

583

624

554

730

467

383

-

-

-

259

382

291

327

326

444

411

363

149

161

219

167

98

122

151

91

Prepaid income taxes

-

-

951

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

258

469

236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

122,868

109,271

101,416

103,018

101,578

98,233

87,669

81,402

82,705

66,380

61,566

58,434

55,158

55,399

55,440

50,605

48,159

38,351

37,530

32,749

28,989

25,148

21,839

20,339

19,549

18,273

16,957

16,430

15,606

13,875

13,088

12,706

14,086

13,086

12,285

12,894

10,095

Long-term investments

9,385

16,569

16,492

8,233

3,635

1,099

5,168

7,163

2,840

5,745

6,717

7,396

8,101

3,771

1,443

2,264

2,471

3,596

1,894

1,437

1,250

1,250

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

68

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets, net

-

-

-

-

-

313

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use asset

220

239

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred royalty buy-down - long term, net

-

-

-

-

-

-

-

-

-

732

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred royalty buy-down - long term, net

-

-

-

-

-

-

0

0

0

-

757

1,156

1,573

1,976

1,913

2,236

2,411

2,851

2,618

3,001

3,085

3,271

3,247

3,309

3,350

3,350

2,750

2,750

2,750

2,750

2,750

2,750

2,750

1,250

1,250

1,250

1,250

Deferred tax assets, net

-

-

0

154

313

-

275

321

403

1,739

2,992

3,072

3,192

3,290

3,370

3,358

3,442

622

620

821

1,062

1,061

1,375

1,377

1,405

1,412

1,412

1,492

1,484

1,484

1,791

1,805

1,738

1,738

1,762

1,804

0

Patent costs, net

564

573

562

493

425

444

439

442

425

397

227

238

248

258

268

267

270

275

285

289

284

295

307

299

322

215

232

248

264

280

210

225

-

190

-

-

-

Other assets

139

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

177

-

164

166

173

Total assets

133,246

126,653

118,471

111,899

105,952

100,092

93,552

89,330

86,374

74,996

72,260

70,297

68,274

64,696

62,436

58,732

56,754

45,698

42,949

38,298

34,671

31,026

26,770

25,326

24,626

23,252

21,352

20,920

20,104

18,390

17,840

17,486

18,752

16,265

15,461

16,115

11,518

Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued expenses

1,628

998

877

710

1,944

1,798

1,116

1,591

1,781

933

785

1,162

1,161

738

-

587

637

611

651

831

783

543

517

719

877

634

538

660

765

512

680

659

2,281

601

732

784

893

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

991

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax payable

1,640

354

0

878

1,802

704

694

801

2,535

68

-

-

-

0

279

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

102

153

-

-

-

-

Current portion of lease obligation

77

69

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

0

0

117

1,057

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

382

332

-

-

-

-

-

-

-

-

Accrued third party development expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

881

2,649

Deferred revenue

-

-

-

-

-

-

-

-

-

-

1,134

1,298

1,362

1,179

1,223

1,065

1,464

149

49

49

49

49

62

69

69

69

69

78

105

133

161

253

345

437

437

437

483

Accrued liabilities of discontinued operations

-

-

-

-

-

-

0

0

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

78

Total current liabilities

3,346

1,422

877

1,589

3,747

2,503

1,810

2,393

4,512

2,138

1,997

2,539

2,602

1,996

2,572

1,730

2,180

838

778

958

911

671

657

866

1,024

781

746

1,199

1,282

724

919

1,093

2,857

1,116

1,248

2,181

4,104

Lease obligation

146

167

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability, net

484

572

593

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

3,977

2,162

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred revenue

-

-

-

-

-

-

0

0

17

5,340

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred revenue

-

-

-

-

-

-

-

-

-

-

5,555

5,661

5,974

6,417

6,642

7,087

6,971

49

61

74

86

98

97

103

120

138

155

172

190

207

224

241

259

276

385

495

713

Commitments and Contingencies

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders' equity:
Series A Preferred stock, $.50 par value, 700,000 shares authorized; none outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $.001 par value; 10,000,000 shares authorized; 7,815,230 and 7,813,230 shares issued, 7,337,511 and 7,339,578 shares outstanding as of March 31, 2020 and December 31, 2019, respectively

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

Additional paid-in capital

39,856

39,355

38,956

38,299

36,502

36,302

36,198

34,424

33,633

33,468

33,303

33,270

33,236

32,945

32,650

32,192

32,159

31,797

31,134

28,681

26,260

25,059

22,657

22,393

21,427

20,951

20,729

20,794

20,715

20,688

20,667

20,404

20,269

20,049

18,697

18,423

17,739

Retained earnings

101,145

96,646

89,292

83,019

76,593

72,176

65,993

60,402

56,102

41,939

39,294

36,579

33,955

30,610

27,694

24,640

22,067

19,238

16,580

13,709

11,951

9,620

7,701

6,306

5,729

4,975

3,249

2,070

1,042

-310

-1,411

-1,882

-2,549

-3,291

-3,363

-3,633

-9,893

Treasury stock, 477,720 and 473,653 shares at cost as of March 31, 2020 and December 31, 2019, respectively

11,740

11,519

11,255

11,016

10,898

10,898

10,457

7,898

7,898

7,898

7,898

7,760

7,503

7,281

7,131

6,925

6,632

6,233

5,612

5,131

4,544

4,430

4,351

4,351

3,682

3,601

3,534

3,323

3,132

2,926

2,566

2,377

2,090

1,891

1,512

1,358

1,151

Total stockholders' equity

129,269

124,491

117,001

110,310

102,205

97,588

91,742

86,936

81,844

67,516

64,707

62,097

59,696

56,281

53,221

49,914

47,602

44,810

42,108

37,265

33,674

30,256

26,014

24,355

23,481

22,332

20,450

19,548

18,631

17,458

16,696

16,151

15,635

14,872

13,828

13,438

6,700

Total liabilities and stockholders' equity

133,246

126,653

118,471

111,899

105,952

100,092

93,552

89,330

86,374

74,996

72,260

70,297

68,274

64,696

62,436

58,732

56,754

45,698

42,949

38,298

34,671

31,026

26,770

25,326

24,626

23,252

21,352

20,920

20,104

18,390

17,840

17,486

18,752

16,265

15,461

16,115

11,518

Series A Preferred Stock [Member]
Series A Preferred stock, $.50 par value, 700,000 shares authorized; none outstanding

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-